Search

Search Constraints

You searched for: Author/Creator Rybka, Justyna

Search Results

1. A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial. Issue 7 (6th June 2020)

2. A survey across orbital lymphoma in Poland: Multicenter retrospective study of polish lymphoma research group (PLRG). (26th September 2022)

3. Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial. Issue 2 (February 2023)

4. Concomitance of monosomal karyotype with at least 5 chromosomal abnormalities is associated with dismal treatment outcome of AML patients with complex karyotype – retrospective analysis of Polish Adult Leukemia Group (PALG). Issue 4 (3rd April 2017)

6. Higher efficacy of intermediate dose cytarabine + G‐CSF compared to cyclophosphamide + G‐CSF in hematopoietic stem cell mobilization in patients with multiple myeloma. Issue 4 (16th April 2020)

7. Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group*. Issue 2 (28th January 2019)

8. Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group. Issue 2 (28th January 2019)

9. Hodgkin lymphoma transformation of chronic lymphocytic leukemia—A real life data from the Polish Lymphoma Research Group. Issue 4 (14th June 2019)

10. Impaired adaptive immune response in COVID‐19 convalescent patients with hematological malignancies. (30th December 2022)